novo nordisk semaglutide patent A Snapshot of the Landscape Natco Pharma sues Novo Nordisk

Additionally, semaglutide is not safe for pregnant and lactating females and children

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

Sam has many years of experience in the aesthetic medicine and has worked with industry professionals for more than a decade

He said: Our long-term analysis of semaglutide in a large and diverse cohort of patients with type 2 diabetes found a clinically relevant improvement in blood sugar control and weight loss after six months of treatment, comparable with that seen in randomised trials